1. COVID-19 vaccination and risk of neuralgic amyotrophy

   News item 25 June 2022 Pages: 1 - 1

2. Magnesium suspensions recalled in US due to contamination

   News item 25 June 2022 Pages: 2 - 2

3. Monitoring for vitamin B12 deficiency in metformin users

   News item 25 June 2022 Pages: 3 - 3

4. PRAC meeting highlights June 2022

   News item 25 June 2022 Pages: 4 - 4

5. Risk of olmesartan-related autoimmune hepatitis

   News item 25 June 2022 Pages: 5 - 5

6. SnoreStop NasoSpray recalled due to microbial contamination

   News item 25 June 2022 Pages: 6 - 6

7. Acute neurological AEs after COVID-19 vaccination

   Clinical study 25 June 2022 Pages: 7 - 7

8. ADEs from asthma medications increasing in paediatric patients

   Clinical study 25 June 2022 Pages: 8 - 8

9. AEs associated with disease-modifying therapies in RRMS

   Clinical study 25 June 2022 Pages: 9 - 9

10. COVID-19 vaccination relatively safe in autoimmune diseases

    Clinical study 25 June 2022 Pages: 10 - 10

11. Immune-related AEs due to ICIs more likely in older patients

    Clinical study 25 June 2022 Pages: 11 - 11

12. Intranasal corticosteroid-related ADRs

    Clinical study 25 June 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 25 June 2022 Pages: 13 - 13

14. Aciclovir/cyclophosphamide

    Case report 25 June 2022 Pages: 14 - 14

15. Ad26.cov2-s

    Case report 25 June 2022 Pages: 15 - 15

16. Adalimumab

    Case report 25 June 2022 Pages: 16 - 16

17. Adalimumab

    Case report 25 June 2022 Pages: 17 - 17

18. Adalimumab/azathioprine/immunosuppressants

    Case report 25 June 2022 Pages: 18 - 18

19. Adalimumab/infliximab

    Case report 25 June 2022 Pages: 19 - 19

20. Adalimumab/steroids

    Case report 25 June 2022 Pages: 20 - 20

21. Afatinib

    Case report 25 June 2022 Pages: 21 - 21

22. Alectinib/nivolumab

    Case report 25 June 2022 Pages: 22 - 22

23. Alendronic-acid

    Case report 25 June 2022 Pages: 23 - 23

24. Allopurinol

    Case report 25 June 2022 Pages: 24 - 24

25. Allopurinol​/carbamazepine/​COVID-19-vaccines

    Case report 25 June 2022 Pages: 25 - 25

26. Amikacin/azithromycin

    Case report 25 June 2022 Pages: 26 - 26

27. Amiodarone/lidocaine

    Case report 25 June 2022 Pages: 27 - 27

28. Amiodarone/sotalol

    Case report 25 June 2022 Pages: 28 - 28

29. Amphotericin-B

    Case report 25 June 2022 Pages: 29 - 29

30. Amphotericin-B

    Case report 25 June 2022 Pages: 30 - 30

31. Amphotericin-B

    Case report 25 June 2022 Pages: 31 - 31

32. Amphotericin-b-liposomal

    Case report 25 June 2022 Pages: 32 - 32

33. Ampicillin/gentamicin

    Case report 25 June 2022 Pages: 33 - 33

34. Ampicillin/vancomycin

    Case report 25 June 2022 Pages: 34 - 34

35. Anakinra/tisagenlecleucel/tocilizumab

    Case report 25 June 2022 Pages: 35 - 35

36. Anthracyclines

    Case report 25 June 2022 Pages: 36 - 36

37. Anti-cd19-chimeric-antigen-receptor-t-cell-therapy-tianjin-mycure-medical-technology

    Case report 25 June 2022 Pages: 37 - 37

38. Anti-D-Rh0-immunoglobulin

    Case report 25 June 2022 Pages: 38 - 38

39. Anti-infectives

    Case report 25 June 2022 Pages: 39 - 39

40. Anti-neoplastics

    Case report 25 June 2022 Pages: 40 - 40

41. Antiarrhythmics

    Case report 25 June 2022 Pages: 41 - 41

42. Antibacterials/antituberculars

    Case report 25 June 2022 Pages: 42 - 42

43. Antibacterials/antituberculars

    Case report 25 June 2022 Pages: 43 - 43

44. Antibacterials/potassium-permanganate/sirolimus

    Case report 25 June 2022 Pages: 44 - 44

45. Anticoagulants/AZD-1222/immunosuppressants

    Case report 25 June 2022 Pages: 45 - 45

46. Antidepressants/anxiolytics/salmeterol

    Case report 25 June 2022 Pages: 46 - 46

47. Antiepileptic drugs

    Case report 25 June 2022 Pages: 47 - 47

48. Antiepileptic-drugs

    Case report 25 June 2022 Pages: 48 - 48

49. Antiepileptic-drugs

    Case report 25 June 2022 Pages: 49 - 49

50. Antiepileptic-drugs

    Case report 25 June 2022 Pages: 50 - 50